سعر تازورينول0.1% جل موضعي 2022

Tazarotene 0.1% topical gel by Medizen Pharmaceutical Industries for Gast Pharma Group (Egypt); topical retinoid listed in the psoriasis category.

• Topical treatment of plaque psoriasis of up to 20% body surface areaPopulation: AdultsDailyMed (U.S. National Library of Medicine)
• Topical treatment of mild to moderate facial acne vulgaris (0.1% gel)DailyMed (U.S. National Library of Medicine)

• Psoriasis: most common (10-30%) are pruritus, burning/stinging, erythema, worsening of psoriasis, irritation and skin pain. Acne: desquamation, burning/stinging, dry skin, erythema and pruritus.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated in pregnancy (retinoids may cause fetal harm).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Contraindicated in individuals with known hypersensitivity to any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Embryofetal toxicity: females of child-bearing potential should have a negative pregnancy test within 2 weeks before starting and use effective contraception during treatment.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Local irritation (pruritus, burning, redness, peeling) may occur; do not use on eczematous skin.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Photosensitivity: avoid sunlight, sunlamps and weather extremes; use sunscreen daily.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Combined oral contraceptive (norethindrone/ethinyl estradiol)Oral tazarotene 1.1 mg did not affect norethindrone/ethinyl estradiol pharmacokinetics; effect on progestin-only pills not evaluated. No formal interaction studies with the gel.DailyMed (U.S. National Library of Medicine)

• Based on animal data, retinoid pharmacology and potential systemic absorption, tazarotene gel may cause fetal harm; it is contraindicated in pregnancy.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk; radioactivity detected in rat milk after topical dosing. Weigh benefits of breastfeeding against maternal need and potential infant risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)